170 related articles for article (PubMed ID: 9772976)
1. [Adenocarcinoma of the Barrett esophagus. Apropos of 44 resected cases].
Lozac'h P; Topart P; Volant A
J Chir (Paris); 1997 Nov; 134(5-6):218-26. PubMed ID: 9772976
[No Abstract] [Full Text] [Related]
2. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
Peracchia A; Bonavina L; Via A; Incarbone R
J Exp Clin Cancer Res; 1999 Sep; 18(3):289-94. PubMed ID: 10606171
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
4. [Treatment procedures for adenocarcinoma of the esophagogastric junction].
Moesta KT; Hünerbein M; Schlag PM
Chirurg; 2003 Apr; 74(4):381-92; quiz 392-3. PubMed ID: 12719881
[No Abstract] [Full Text] [Related]
5. Neoadjuvant treatment of oesophageal adenocarcinoma.
Robb WB; Naughton P; Walsh TN
Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
[TBL] [Abstract][Full Text] [Related]
6. [Surgical treatment of Barrett carcinoma].
Fuchs KH
Zentralbl Chir; 2000; 125(5):443-9. PubMed ID: 10929629
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
9. Exclusive radical surgery for esophageal adenocarcinoma.
Collard JM
Cancer; 2001 Mar; 91(6):1098-104. PubMed ID: 11267954
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
Liu JF; Jamieson GG; Wu TC; Zhu GJ; Drew PA
Ann Surg Oncol; 2009 May; 16(5):1397-402. PubMed ID: 19241108
[TBL] [Abstract][Full Text] [Related]
11. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
Strickland AH; Karapetis CS; Yip D; Harper PG
Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
[No Abstract] [Full Text] [Related]
14. Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group.
Armanios M; Xu R; Forastiere AA; Haller DG; Kugler JW; Benson AB;
J Clin Oncol; 2004 Nov; 22(22):4495-9. PubMed ID: 15542799
[TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant treatment of operable esophageal cancers].
Azria D; Ychou M; Senesse P; Dubois JB
Gastroenterol Clin Biol; 1999 Oct; 23(10):1107-8. PubMed ID: 10592891
[No Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the duplicated muscularis mucosae in Barrett esophagus-related superficial adenocarcinoma.
Kaneshiro DK; Post JC; Rybicki L; Rice TW; Goldblum JR
Am J Surg Pathol; 2011 May; 35(5):697-700. PubMed ID: 21490446
[TBL] [Abstract][Full Text] [Related]
18. [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].
Faivre C; Rougier P; Ducreux M; Mitry E; Lusinchi A; Lasser P; Elias D; Eschwege F
Bull Cancer; 1999 Oct; 86(10):861-5. PubMed ID: 10572237
[TBL] [Abstract][Full Text] [Related]
19. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
DeMeester SR
Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
[No Abstract] [Full Text] [Related]
20. [First-line chemo-radiotherapy neoadjuvant treatment in locally advanced (T4) epidermoid carcinoma of the esophagus].
Ancona E; Merigliano S; Petrin G; Cagol M; Scappin S; Koussis H; Boso C; Chiarion Sileni V; Corti L; Ruol A
Chir Ital; 1999; 51(2):91-7. PubMed ID: 10514923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]